glp 1 multiple sclerosis A Phase 2 trial just began testing whether a GLP-1 drug can slow brain shrinkage Emerging research suggests that GLP-1

10.1016/j.mce.2013.04.014 Mol

Arsenic as a food chain contaminant: mechanisms of plant uptake and metabolism and mitigation strategies

As an injectable medication, it has shown promising effects in controlling hunger and promoting weight loss by targeting areas of the brain that influence food intake

10.1038/s41598-021-99025-1 Sci

It used three probabilities (ranging from 0 to 1) to determine the nature of the sentiment within the text, classified as negative, neutral, or positive sentiment. Results and discussion About 97.1% of the discussions focused on GLP-1 RA medications prescribed for weight loss, such as semaglutide, tirzepatide, and liraglutide, with Ozempic being the most discussed (41.4%), despite not being approved by the US Food and Drug Administration (FDA) for weight loss

Amplification effects